Indeed, a simple analysis of the cell surface signatures discovered in recent years for putative prostate cancer stem cells by different groups (Table 1) reveals that every one of these signatures contains at least one, or two, or even three TF-Ag glycoprotein carriers. Here, RENBP is linked to prostate carcinoma.